Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 424,171
  • Shares Outstanding, K 77,122
  • Annual Sales, $ 3,660 K
  • Annual Income, $ -819,380 K
  • 60-Month Beta 1.29
  • Price/Sales 133.52
  • Price/Cash Flow N/A
  • Price/Book 2.52
Trade BLUE with:

Options Overview Details

View History
  • Implied Volatility 172.47% ( +5.86%)
  • Historical Volatility 124.31%
  • IV Percentile 96%
  • IV Rank 62.45%
  • IV High 240.00% on 05/19/22
  • IV Low 60.13% on 08/16/21
  • Put/Call Vol Ratio 0.12
  • Today's Volume 1,411
  • Volume Avg (30-Day) 3,840
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 68,690
  • Open Int (30-Day) 52,564

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.21
  • Number of Estimates 9
  • High Estimate -0.83
  • Low Estimate -1.73
  • Prior Year -2.93
  • Growth Rate Est. (year over year) +58.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.74 +54.41%
on 08/01/22
6.35 -9.06%
on 08/08/22
+0.63 (+12.14%)
since 07/08/22
3-Month
2.87 +101.57%
on 06/02/22
6.35 -9.06%
on 08/08/22
+1.93 (+50.00%)
since 05/10/22
52-Week
2.87 +101.57%
on 06/02/22
25.39 -77.25%
on 11/04/21
-14.27 (-71.18%)
since 08/10/21

Most Recent Stories

More News
bluebird (BLUE) Q2 Loss Narrower Than Expected, Sales Miss

bluebird (BLUE) posts a narrower-than-expected loss in the second quarter. However, sales miss estimates.

DVAX : 17.11 (+0.53%)
ALKS : 25.52 (-0.31%)
BLUE : 5.79 (+5.27%)
TSVT : 17.39 (+4.13%)
Bluebird Bio (BLUE) Reports Q2 Loss, Lags Revenue Estimates

Bluebird (BLUE) delivered earnings and revenue surprises of 1.53% and 76.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

BLUE : 5.79 (+5.27%)
CERT : 20.75 (-9.15%)
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates

Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of 15.15% and 62.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

PTGX : 11.43 (+3.63%)
BLUE : 5.79 (+5.27%)
bluebird bio Reports Second Quarter 2022 Financial Results and Highlights Operational Progress

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the second quarter ended June 30, 2022, and shared recent operational...

BLUE : 5.79 (+5.27%)
1 Reason to Buy Bluebird Bio, and 1 Reason to Sell

The biotech has lost a substantial of its market value over the past three years.

BLUE : 5.79 (+5.27%)
Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Bluebird (BLUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BLUE : 5.79 (+5.27%)
NGM : 17.30 (+6.53%)
Alkermes (ALKS) Q2 Earnings and Revenues Top Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of 50% and 1.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ALKS : 25.52 (-0.31%)
BLUE : 5.79 (+5.27%)
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week

These high-tech biotech stocks made a sharp U-turn this week after a rough start to the year.

BLUE : 5.79 (+5.27%)
CRSP : 77.80 (+3.55%)
EDIT : 18.27 (+1.56%)
Bluebird (BLUE) Surges 18%: Is This an Indication of Further Gains?

Bluebird (BLUE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BLUE : 5.79 (+5.27%)
VNDA : 10.40 (+1.27%)
Why Bluebird Bio Stock Is Flying Today

There's probably a short squeeze in progress.

BLUE : 5.79 (+5.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 6.53
2nd Resistance Point 6.32
1st Resistance Point 5.91
Last Price 5.79
1st Support Level 5.29
2nd Support Level 5.08
3rd Support Level 4.67

See More

52-Week High 25.39
Fibonacci 61.8% 16.79
Fibonacci 50% 14.13
Fibonacci 38.2% 11.47
Last Price 5.79
52-Week Low 2.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar